No Data
FanPep, Kids Bio, and others.
The forecast for this period's operating profit has been revised down to 0.39 billion yen from 1.619 billion yen.
BOJ Seeks More Rate Hikes but Not in Rush, Deputy Governor Says -- 2nd Update
February 19 [Today's Investment Strategy]
[Fisco Selected Stocks] 【Material Stocks】 Fusoh Chemical Industry <4368> 3500 yen (2/18) engages in ultra-high purity colloidal silica used in Food Additives such as malic acid and polishing materials for Semiconductor wafers. The performance Financial Estimates for the fiscal year ending March 2025 have been revised upward. The operating profit is expected to be 160 yen (an increase of 44.3% compared to the previous term). This is an increase of about 18% from the previous estimate. Sales for the Semiconductor market are strong. The effects of the weak yen are also contributing. The year-end Dividends are set at 38 yen. The previous estimate was 35 yen, and the year-end of the previous term.
Focus on Fusso Chemicals and Konishi, the trends ETC seem to be weak.
In the US stock market yesterday, on the 18th, the Dow Jones Industrial Average rose by $10.26 to 44,556.34, the Nasdaq Composite Index increased by 14.49 points to 20,041.26, and the Chicago Nikkei 225 Futures were up by 10 yen compared to the Osaka daytime, reaching 39,300 yen. The exchange rate is 1 dollar = 152.00-10 yen. In today's Tokyo market, Fusoh Chemicals <4368> announced an upward revision of the financial estimates and dividends for the fiscal year ending March 2025, reporting a special profit from the sale of investment securities amounting to 0.397 billion yen and implementing a 5.0 yen commemorative dividend for the 100th anniversary.
Immunobiology Research Institute, Genepha, etc.
＜3195＞ Obtained a patent for filling materials containing Genepacapok fibers and feathers and their manufacturing devices and methods. <3558> Changed the Jade Group Shareholder benefit program. <3905> Issuance of the 20th subscription rights by Data Section (with exercise price adjustment provisions, potential number of stocks is 4.4 million shares, raising approximately 3.024 billion yen). <3967> Recorded a special profit of 0.015 billion yen from the sale of investment securities by Eltes. <4058> Completed the acquisition of treasury shares by Toyokumo. <4570> Immunobiological Research Institute.
Express News | Regarding the shareholding of Jade Group (3558.JP) stocks, Arcus Investment Limited submitted a corrected report (5% rule report) to the Ministry of Finance on January 21.
